$BRLI News

Last published 2y ago

2y agoBRLINukkleus, Inc. Finalizes Transformative Merger with Brilliant Acquisition Corp, Unveiling New Horizons in Digital Asset Solutions for CustomersPR NewswireNukkleus, Inc. (formerly Compliance & Risk Management Solutions Inc.) (OTC: NUKK) proudly announces the completion of its strategic merger with...
2y agoBRLI BRLIR BRLIU BRLIWBrilliant Acquisition Corporation Announces Extension of Completion Window to December 23, 2023GlobeNewswireNew York, Nov. 22, 2023 (GLOBE NEWSWIRE) -- Brilliant Acquisition Corporation ("Brilliant") announced today that it has extended the period of time it will have to consummate its initial business combination by a
3y agoBRLI BRLIR BRLIU BRLIWBrilliant Acquisition Corporation Announces Extension of Completion Window to November 23, 2023GlobeNewswireNew York, Oct. 20, 2023 (GLOBE NEWSWIRE) -- Brilliant Acquisition Corporation ("Brilliant") announced today that it has extended the period of time it will have to consummate its initial business combination by a
3y agoBRLI BRLIR BRLIU BRLIWBrilliant Acquisition Corporation Announces Extension of Completion Window to October 23, 2023GlobeNewswireNew York, Sept. 22, 2023 (GLOBE NEWSWIRE) -- Brilliant Acquisition Corporation ("Brilliant") announced today that it has extended the period of time it will have to consummate its initial business combination by a
3y agoBRLI BRLIR BRLIU BRLIWBrilliant Acquisition Corporation Announces Extension of Completion Window to September 23, 2023GlobeNewswireNew York, Aug. 23, 2023 (GLOBE NEWSWIRE) -- Brilliant Acquisition Corporation ("Brilliant") announced today that it has extended the period of time it will have to consummate its initial business combination by a
3y agoBRLI BRLIR BRLIU BRLIWBrilliant Acquisition Corporation Announces Extension of Completion Window to August 23, 2023GlobeNewswireNew York, July 21, 2023 (GLOBE NEWSWIRE) -- Brilliant Acquisition Corporation ("Brilliant") announced today that it has extended the period of time it will have to consummate its initial business combination by a
3y agoBRLI BRLIR BRLIU BRLIWBrilliant Acquisition Corporation Announces Extension of Completion Window to July 23, 2023GlobeNewswireJune 23, 2023 | Source: Brilliant Acquisition Corporation New York, June 23, 2023 (GLOBE NEWSWIRE) -- Brilliant Acquisition Corporation ("Brilliant") announced today that it has extended the period of time it
3y agoBRLI BRLIR BRLIU BRLIWBrilliant Acquisition Corporation Announces Extension of Completion Window to June 23, 2023GlobeNewswireMay 23, 2023 | Source: Brilliant Acquisition Corporation New York, May 23, 2023 (GLOBE NEWSWIRE) -- Brilliant Acquisition Corporation ("Brilliant") announced today that it has extended the period of time it will
3y agoBRLI BRLIR BRLIU BRLIWBrilliant Acquisition Corporation Announces Extension of Completion Window to May 23, 2023GlobeNewswireApril 21, 2023 | Source: Brilliant Acquisition Corporation New York, April 21, 2023 (GLOBE NEWSWIRE) -- Brilliant Acquisition Corporation ("Brilliant") announced today that it has extended the period of time
3y agoBRLI BRLIR BRLIU BRLIWBrilliant Acquisition Corporation Announces Extension of Completion Window to April 23, 2023GlobeNewswireNew York, March 22, 2023 (GLOBE NEWSWIRE) -- Brilliant Acquisition Corporation ("Brilliant") announced today that it has extended the period of time it will have to consummate its initial business combination by a
3y agoBRLI BRLIR BRLIU BRLIWBrilliant Acquisition Corporation Announces Extension of Completion Window to March 23, 2023GlobeNewswireFebruary 23, 2023 | Source: Brilliant Acquisition Corporation New York, Feb. 23, 2023 (GLOBE NEWSWIRE) -- Brilliant Acquisition Corporation ("Brilliant") announced today that it has extended the period of time
3y agoBRLI BRLIR BRLIU BRLIWBrilliant Acquisition Corporation Announces Extension of Completion Window to February 23, 2023GlobeNewswireJanuary 24, 2023 | Source: Brilliant Acquisition Corporation New York, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Brilliant Acquisition Corporation ("Brilliant") announced today that it has extended the period of time
3y agoBRLI BRLIR BRLIU BRLIWBrilliant Acquisition Corporation Announces Extension of Completion Window to January 23, 2023GlobeNewswireDecember 19, 2022 | Source: Brilliant Acquisition Corporation New York, Dec. 19, 2022 (GLOBE NEWSWIRE) -- Brilliant Acquisition Corporation ("Brilliant") announced today that it has extended the period of time
3y agoBRLI BRLIR BRLIU BRLIWBrilliant Acquisition Corporation Announces Extension of Completion Window to December 23, 2022GlobeNewswireNew York, Nov. 18, 2022 (GLOBE NEWSWIRE) -- Brilliant Acquisition Corporation ("Brilliant") announced today that it has extended the period of time it will have to consummate its initial business combination by a
4y agoBRLI BRLIR BRLIU BRLIWBrilliant Acquisition Corporation Announces Extension of Completion Window to November 23, 2022GlobeNewswireOctober 19, 2022 | Source: Brilliant Acquisition Corporation New York, Oct. 19, 2022 (GLOBE NEWSWIRE) -- Brilliant Acquisition Corporation ("Brilliant") announced today that it has extended the period of time
4y agoBRLI BRLIR BRLIU BRLIWBrilliant Acquisition Corporation Announces Extension of Completion Window to October 23, 2022GlobeNewswireNew York, July 19, 2022 (GLOBE NEWSWIRE) -- Brilliant Acquisition Corporation ("Brilliant") announced today that it has extended the period of time it will have to consummate its initial business combination by a further three months, or until October
4y agoBRLI BRLIR BRLIU BRLIWBrilliant Acquisition Corporation Announces the Filing of a Registration Statement on Form S-4 in Connection with its Business Combination with Nukkleus Inc.GlobeNewswireNEW YORK, April 18, 2022 (GLOBE NEWSWIRE) -- Brilliant Acquisition Corporation (NASDAQ:BRLI) ("Brilliant or the Company"), a publicly-traded special purpose acquisition company formed in the British Virgin Islands, today announced that a Registration S
4y agoBRLIBrilliant Acquisition Corporation Announces Extension of Completion Window to July 23, 2022PR NewswireNEW YORK, March 22, 2022 /PRNewswire/ -- Brilliant Acquisition Corporation ("Brilliant") announced today that it has extended the period of time it will have to consummate its initial business combination by a further four months, or until July 23, 2022
4y agoBRLIBrilliant Acquisition Corp announces entry into material agreement with Nukkleus Inc.PR NewswireNEW YORK, Feb. 24, 2022 /PRNewswire/ -- Brilliant Acquisition Corp (NASDAQ:BRLI) ("Brilliant or the Company"), a publicly-traded special purpose acquisition company formed in the British Virgin Islands, yesterday announced the signing of a merger agreeme
4y agoBRLI NUKKNukkleus, Inc., a market leader in modern global payments and multi-asset trading technology, to combine with Brilliant Acquisition Corp.PR NewswireNEW YORK, Feb. 23, 2022 /PRNewswire/ -- Nukkleus, Inc. (f/k/a Compliance & Risk Management Solutions Inc.) (OTC:NUKK) ("Nukkleus" or the "Company"), today announced the signing of a merger agreement for a proposed business combination with Brilliant Ac
4y agoBRLI BRLIR BRLIU BRLIWBrilliant Acquisition Corporation Announces Extension of Completion Window to March 25, 2022GlobeNewswireNew York, Dec. 23, 2021 (GLOBE NEWSWIRE) -- Brilliant Acquisition Corporation (the "Company") announced today that it has extended the period of time it will have to consummate its initial business combination by 3 months from the current deadline of
5y agoBRLI BRLIR BRLIU BRLIWBrilliant Acquisition Corporation Announces Extension of Completion Window to December 25, 2021GlobeNewswireNew York, Sept. 21, 2021 (GLOBE NEWSWIRE) -- Brilliant Acquisition Corporation (the "Company") announced today that it has extended the period of time it will have to consummate its initial business combination by 3 months from the current deadline of
5y agoBRLI BRLIR BRLIU BRLIWBrilliant Acquisition Corporation: New SEC Guidance Relating to SPAC Warrants, Its Effect on the Company's Periodic Filings and Compliance with Nasdaq RulesGlobeNewswireNew York, Aug. 31, 2021 (GLOBE NEWSWIRE) -- Brilliant Acquisition Corporation (the "Company") announced today that, as the result of the U.S. Securities and Exchange Commission's ("SEC's") recent guidance, released on April 12, 2021 relating to the a
5y agoBRLI BRLIR BRLIUBrilliant Acquisition Corporation Announces Timely Deposit of Additional Funds By Its SponsorGlobeNewswireNew York, June 28, 2021 (GLOBE NEWSWIRE) -- Brilliant Acquisition Corporation (the "Company") announced today that its Sponsor, Nisun Investment Holding Limited has timely deposited $460,000 in the Company's trust account, pursuant to the terms of the
5y agoBRLI BRLIR BRLIUBrilliant Acquisition Corporation Announces Extension of Completion Window to September 25, 2021GlobeNewswireNew York, June 22, 2021 (GLOBE NEWSWIRE) -- Brilliant Acquisition Corporation (the "Company") announced today that it has extended the period of time it will have to consummate its initial business combination by 3 months from the current deadline of
5y agoBRLI BRLIR BRLIUBrilliant Acquisition Corporation: New SEC Guidance Relating to SPAC Warrants, Its Effect on the Company's Periodic Filings and Compliance with Nasdaq RulesGlobeNewswireNew York, June 08, 2021 (GLOBE NEWSWIRE) -- Brilliant Acquisition Corporation (the "Company") announced today that, as the result of the U.S. Securities and Exchange Commission's ("SEC's") recent guidance, released on April 12, 2021 relating to the acc
5y agoBRLI BRLIR BRLIU BRLIWBrilliant Acquisition Corporation: New SEC Guidance Relating to SPAC Warrants, Its Effect on the Company's Periodic Filings and Compliance with Nasdaq RulesGlobeNewswireNew York, April 19, 2021 (GLOBE NEWSWIRE) -- Brilliant Acquisition Corporation (the "Company") announced today that, as the result of the U.S. Securities and Exchange Commission's ("SEC's") recent guidance, released on April 12, 2021 relating to the ac
11y agoOPK BRLIOPKO Completes Acquisition of Bio-Reference LaboratoriesBusiness WireMIAMI--(BUSINESS WIRE)--OPKO Health, Inc. (NYSE: OPK) and Bio-Reference Laboratories, Inc. (NASDAQ: BRLI) today announced the completion of the acquisition of Bio-Reference by OPKO. Shareholders of Bio-Reference will receive 2.75 shares of OPKO common stock for each share of Bio-Reference common stock.
11y agoOPK BRLIOPKO and Bio-Reference Laboratories Announce Early Termination of the Waiting Period for Planned AcquisitionBusiness WireMIAMI--(BUSINESS WIRE)--OPKO Health, Inc. (NYSE:OPK) and Bio-Reference Laboratories, Inc. (NASDAQ:BRLI), today announced that early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (the "HSR Act") has been granted, effective July 1, 2015, for OPKO's planned acquisition of Bio-Reference.
11y agoBRLIThe Proposed Acquisition Of Bio-Reference Laboratories, Inc Is Under Investigation By The Young Law Center LLCBusiness WirePHOENIXVILLE, Pa.--(BUSINESS WIRE)--The Young Law Center LLC (the “Firm”), a shareholder litigation firm, is investigating potential claims concerning the proposed acquisition of Bio-Reference Laboratories, Inc (“BRLI” or the “Company”) (NASDAQ: “BRLI”). On or about June 4, 2015 the Company announced it had signed a definitive merger agreement under which OPKO Health, Inc will acquire BRLI and tha ...
11y agoOPK BRLIOPKO and Bio-Reference Laboratories To Hold Joint Conference Call to Discuss MergerBusiness WireMIAMI--(BUSINESS WIRE)--OPKO Health, Inc. (NYSE:OPK) and Bio-Reference Laboratories, Inc. (NASDAQ: BRLI) will host a joint conference call and webcast at 8:30 a.m. ET on Thursday, June 11, 2015, to discuss the previously announced entry into a merger agreement for OPKO to acquire Bio-Reference Laboratories and to discuss Bio-Reference Laboratories’ second quarter financial results. This joint call ...
11y agoBRLILaw Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Bio-Reference Laboratories, Inc. StockholdersBusiness WireNEW YORK--(BUSINESS WIRE)--Kirby McInerney LLP is investigating potential claims against the Board of Directors of Bio-Reference Laboratories, Inc. (“BRLI” or the “Company”) (NASDAQ:BRLI) concerning the proposed acquisition of the Company by OPKO Health, Inc. (“OPKO”). Pursuant to the terms of the definitive merger agreement, BRLI stockholders will receive 2.75 shares of OPKO common stock for each ...
11y agoOPK BRLIOPKO Health to Acquire Bio-Reference LaboratoriesBusiness WireMIAMI--(BUSINESS WIRE)--OPKO HEALTH, INC. (NYSE:OPK) and Bio-Reference Laboratories, Inc. (NASDAQ:BRLI) today announced that the companies have signed a definitive merger agreement under which OPKO will acquire Bio-Reference Laboratories. Bio-Reference Laboratories is the third largest full service clinical laboratory in the United States and is known for its innovative technological solutions and ...
13y agoBRLIBio-Reference Laboratories, Inc. Announces Record Revenues and Earnings for Fourth Quarter and for Full Fiscal Year Despite Effects of Hurricane SandyBusiness WireELMWOOD PARK, N.J.--(BUSINESS WIRE)--(except for per share data or where otherwise noted, numbers are in thousands) Bio-Reference Laboratories, Inc. (NASDAQ: BRLI) announces best-ever quarterly and annual fiscal year results for revenues and earnings. The Company recorded Q4FY12 revenues of $176,052, the strongest quarterly revenues in corporate history (despite Management’s estimate that revenues ...
13y agoBRLIBioReference Laboratories, Inc. Announces Earnings Date for Fourth Quarter and Year End for Fiscal Year 2012Business WireELMWOOD PARK, N.J.--(BUSINESS WIRE)--Bio-Reference Laboratories, Inc. (NASDAQ: BRLI) announced today it plans to issue earnings results for the fourth quarter and year end for fiscal year 2012 before the open of market trading on Thursday, December 6, 2012. The Company’s earnings conference call is to take place the same day at 10:30 a.m. EST. The call will be hosted by Marc D. Grodman M.D., Presi ...
14y agoBRLIBio-Reference Laboratories, Inc. Reports Best Quarterly Revenues and Earnings in Corporate History with 25% Increase in Earnings Per ShareBusiness WireELMWOOD PARK, N.J.--(BUSINESS WIRE)--(Except for Per Share Data or where otherwise noted, numbers are in thousands) Bio-Reference Laboratories, Inc. (NASDAQ: BRLI) announced that the Company recorded current quarter revenues of $172,302, an increase of 16% over the $148,029 recorded in the third quarter, fiscal year 2011. Net income after taxes in Q3FY11 was $12,596 resulting in fully diluted earn ...
14y agoBRLIBioReference Laboratories, Inc. Announces Earnings Date for Third Quarter Fiscal Year 2012Business WireELMWOOD PARK, N.J.--(BUSINESS WIRE)--BioReference Laboratories, Inc. (NASDAQ: BRLI) announced today it plans to issue earnings results for the third quarter of Fiscal 2012 before the open of market trading on Thursday, August 30, 2012. The Company’s earnings conference call is to take place the same day at 10:30 a.m. EST. The call will be hosted by Marc D. Grodman M.D., President and Chief Executi ...
14y agoBRLIGenPath Diagnostics of BioReference Laboratories, Inc. Awarded 2012 Clinical Diagnostics Company of the Year Award by Frost & SullivanBusiness WireELMWOOD PARK, N.J.--(BUSINESS WIRE)--Based on its recent analysis of the clinical diagnostics market, Frost & Sullivan recognized GenPath Diagnostics, a business unit of BioReference Laboratories, Inc. with the 2012 North American Frost & Sullivan Award for Company of the Year. As a BioReference specialized cancer laboratory, GenPath is a major factor to the Company’s impressive growth trajectory— ...
14y agoBRLIBio-Reference Laboratories, Inc. Reports Strong Quarterly ResultsBusiness WireELMWOOD PARK, N.J.--(BUSINESS WIRE)--(Numbers in thousands except per share data or where otherwise noted.) Bio-Reference Laboratories, Inc. (NASDAQ: BRLI) released its second quarter, fiscal year 2012 earnings today for the three months ended April 30. The Company recorded current quarter revenues of $163,388, the highest quarter in corporate history, representing an increase of 19% over the $137 ...
14y agoBRLIBioReference Laboratories, Inc. Announces Earnings Date for Second Quarter Fiscal Year 2012Business WireELMWOOD PARK, N.J.--(BUSINESS WIRE)--Bio-Reference Laboratories, Inc. (NASDAQ: BRLI) announced today it plans to issue earnings results for the second quarter of Fiscal 2012 before the open of market trading on Thursday, June 7, 2012. The Company’s earnings conference call is to take place the same day at 10:30 a.m. EDT. The call will be hosted by Marc D. Grodman M.D., President and Chief Executiv ...
14y agoBRLIBRLI Announces InCellDx Investment and Launch of GenCerv Test Through its GenPath Women’s Health LaboratoryBusiness WireELMWOOD PARK, N.J.--(BUSINESS WIRE)--Bio-Reference Laboratories, Inc. (“BRLI”) (NASDAQ: BRLI) announced today that it has completed an equity investment in InCellDx, Inc. (“InCellDx”), a privately held molecular diagnostics start-up company dedicated to the detection and monitoring of life -threatening diseases such as cervical cancer, breast cancer, HIV/AIDs, hepatitis and organ transplant reject ...
14y agoBRLIBio-Reference Laboratories, Inc. Announces Record First Quarter Revenue, Earnings and Cash Flow from OperationsBusiness WireELMWOOD PARK, N.J.--(BUSINESS WIRE)--(except for per share data or where otherwise noted, numbers are in thousands) Bio-Reference Laboratories, Inc. (NASDAQ: BRLI) announces best-ever first quarter results for revenues, earnings and cash. The Company recorded Q1FY12 revenues of $149,919, an increase of 23% over the $121,659 recorded in Q1FY11. Net income before taxes in Q1FY12 totaled $12,966; an ...
14y agoBRLIBio-Reference Laboratories, Inc. Announces Earnings Date for First Quarter Fiscal Year 2012Business WireELMWOOD PARK, N.J.--(BUSINESS WIRE)--Bio-Reference Laboratories, Inc. (NASDAQ: BRLI) announced today it plans to issue earnings results for the first quarter of Fiscal 2012 before the open of market trading on Thursday, March 1, 2012. The Company’s earnings conference call is to take place the same day at 10:30 a.m. EST. The call will be hosted by Marc D. Grodman M.D., President and Chief Executiv ...
14y agoBRLIBioReference Announces 2012 Annual Meeting DateBusiness WireELMWOOD PARK, N.J.--(BUSINESS WIRE)--Bio-Reference Laboratories, Inc. (“BioReference”) (NASDAQ: BRLI) announced today that it will hold its 2012 annual meeting of stockholders (the “Annual Meeting”) on July 12, 2012. The time and location of the Annual Meeting will be as set forth in BioReference’s annual proxy statement for the Annual Meeting. The record date for determining the holders of the Co ...
14y agoBRLIBioReference to Launch Groundbreaking Solid Tumor Genotyping Test through its GenPath Oncology LaboratoryBusiness WireELMWOOD PARK, N.J.--(BUSINESS WIRE)--BioReference Laboratories, Inc. (NASDAQ: BRLI) and its GenPath Oncology business unit and through its exclusive commercialization agreement with the Massachusetts General Hospital (MGH) is introducing its groundbreaking solid tumor genotype test. The test – which will be marketed as OnkoMatchTM – will help oncologists match patients with cancer therapies tailor ...
14y agoBRLIBioReference Laboratories, Inc. Announces Contract with Corizon, Inc. to Provide Correctional Healthcare Laboratory ServicesBusiness WireELMWOOD PARK, N.J.--(BUSINESS WIRE)--Bio-Reference Laboratories, Inc. (NASDAQ: BRLI) announced that effective January 1, 2012, it has entered into a new Master Agreement to provide diagnostic laboratory services for some of the facilities that Corizon, Inc. services around the country providing contract healthcare services to state and local prisons. Corizon was formed during 2011 as a result of t ...
14y agoBRLIBio-Reference Laboratories, Inc. Announces Record Revenues, Earnings and Cash Flow for Fourth Quarter and Full Fiscal YearBusiness WireELMWOOD PARK, N.J.--(BUSINESS WIRE)--(except for per share data or where otherwise noted, numbers are in thousands) Bio-Reference Laboratories, Inc. (NASDAQ: BRLI) announces best-ever quarterly and annual fiscal year results for revenues, earnings and cash. The Company recorded Q4FY11 revenues of $151,297, the strongest quarterly revenues in corporate history and an increase of 20% over the $126,5 ...
14y agoBRLIBioReference Laboratories, Inc. Announces Earnings Date for Fourth Quarter and Year End for Fiscal Year 2011Business WireELMWOOD PARK, N.J.--(BUSINESS WIRE)--Bio-Reference Laboratories, Inc. (NASDAQ: BRLI) announced today it plans to issue earnings results for the fourth quarter and fiscal year 2011 before the open of market trading on Thursday, December 8th, 2011. The Company’s earnings conference call is to take place the same day at 10:30 a.m. EST. The call will be hosted by Marc D. Grodman M.D., President and Ch ...
14y agoBRLIBioReference Laboratories, Inc. to Speak at the Oppenheimer 22nd Annual Healthcare ConferenceBusiness WireELMWOOD PARK, N.J.--(BUSINESS WIRE)--Bio-Reference Laboratories, Inc. (NASDAQ-“BRLI”) announced today that Marc D. Grodman M.D., President and Chief Executive Officer, is scheduled to speak at the Oppenheimer 22nd Annual Healthcare Conference on Wednesday, December 14, 2011, at The Waldorf Astoria Hotel located in New York, NY. The BioReference Laboratories presentation is scheduled to begin at 1: ...
14y agoBRLIBio-Reference Laboratories, Inc. and McKesson Specialty Health’s Onmark GPO Execute Purchasing AgreementBusiness WireELMWOOD PARK, N.J.--(BUSINESS WIRE)--Bio-Reference Laboratories, Inc. (NASDAQ: BRLI) announced today that it has entered into a purchasing agreement with a McKesson Specialty Health group purchasing organization (GPO), the Onmark GPO. The Onmark GPO delivers a range of services to its members that now include a contract for the routine and specialized services of the Bio-Reference family of clinic ...